Home » Focus on Pharma Podcast: Episode 3: Inside the FDA and the New Transparency Initiative
Focus on Pharma Podcast: Episode 3: Inside the FDA and the New Transparency Initiative
Accused of being too chummy with the drug industry, FDA has moved to improve transparency. CDER's Helen Winkle discusses the initiative's progress.
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page